Thinly traded nano cap Cleveland BioLabs (CBLI +110.5%) is up on a whopping 119x surge in volume, caught up in the COVID-19 tsunami. Investors are falling all over themselves to buy shares in vaccine developers, which are commonly combined with an immune system booster called an adjuvant, in light of stubbornly high infection rates in many parts of the world.
CBLI has such an adjuvant, dubbed SA-702, that is ready for testing.
seekingalpha.com/new...vaccine-stoked-rally
CBLI has such an adjuvant, dubbed SA-702, that is ready for testing.
seekingalpha.com/new...vaccine-stoked-rally